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  Mammalian epidermis is a dynamic, multilayer, protective barrier that 
provides essential protection against environmental insults and prevents water 
loss. The outermost layer, the stratum corneum (SC), is composed of 
corneocytes, which are filled with microfibrillar keratins, surrounded by a 
structurally reinforced, insoluble scaffold surrounded by a lipid matrix. These 
components are essential for barrier function.  
  Previous studies in the Coulombe laboratory revealed that K14-dependent 
disulfide bond formation impacts the assembly, organization, and dynamics of 
keratin intermediate filaments in skin keratinocytes in ex vivo culture.  In 
particular, cysteine (Cys or C) residue in 367 in human K14 (corresponding to 
Cys 373 in mouse K14) was found to play a key role in these processes. To 
investigate the consequences of disrupting K14-dependent disulfide bond 
formation for the structure and function of the epidermis we generated 
Krt14C373A mutant mice using CRISPR/Cas9 technology. Analysis of proteins 
isolated from adult ear and tail skin of Krt14C373A mice, performed under non-
reducing conditions, revealed a significant decrease in disulfide-bonded K14 
species of high molecular weights in comparison to wild type (WT). Additionally, 
the processing of filaggrin, a key effector of terminal differentiation and barrier 
formation, was shown to be altered alongside hyperproliferation and 
hyperkeratosis in the epidermis of the mutant mouse, again relative to control. 
  The current study continues the investigation of epidermal structure and 
barrier function in Krt14C373A mouse. At the outset of this effort we 
	 iii		
hypothesized that thorough analysis of barrier function would reveal defects in 
the skin barrier of Krt14C373A mice relative to the control.   
  Here we report that adult Krt14C373A mice exhibit a significant increase in 
transepidermal water loss (TEWL) under baseline condition. Further, mutant 
mice show heightened sensitivity to chemical challenges at the skin barrier. 
Histological examinations of the adult ear uncovered a modest disruption in the 
SC of Krt14C373 mice following acetone irritation.  Analysis of cornified envelope 
(CE) from ear and tail epidermis revealed alterations in their area and 
morphology.  Immunofluorescence staining revealed decreases in lipid 
abundance in the epidermis following acetone treatment. These and other 
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Keratin family of proteins 
	
Keratin intermediate filaments play central roles in eukaryotic cells 
pertaining to the cytoskeletal network architecture, mechanical support, and 
several cellular functions in differentiated epithelium (Coulombe, 2007). In 
vertebrate epidermis, keratin intermediate filaments represent an astounding 85% 
of total proteins within a differentiated keratinocyte (Fuchs, 1995). Almost two-
thirds of the keratin gene family is found in skin epithelium (Coulombe, 2007).  
 Within the human genome, keratin proteins originate from a group of 54 
conserved keratin genes that are divided into two groups, 28 type I and 26 type II 
(see Figure 1a) (Schweizer et al., 2006). Type I keratin proteins are smaller and 
have an overall acidic charge (see Figure1a) (40- 64k; pI 4.7-7.6), whereas type II 
keratins as typically larger and neutral or basic in charge (50-70kDa; pI ~5.4-8.4) 
(Moll et al., 1982; Schweizer et al., 2006). Moreover, Type I and Type II keratin 
genes are regulated in a pairwise fashion in vivo (Kim and Coulombe, 2007). When 
keratin proteins polymerize they intrinsically co-assemble into coil-coiled 
heterodimers forming an intermediate filament network consisting of 10-12 nm 
wide filaments and can be visualized in vitro (see Figure 1b) (Steinert et al., 1976; 
Fuchs and Cleveland, 1998; Kim and Coulombe, 2007). Keratins possess a 
standard tripartite secondary structure, consisting of a central, alpha-helical rod 
domain flanked by 2 non-helical domains, an N-terminal head and a C-terminal tail 
(see Figure 1c) (Coulombe, 2007).  
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The expression and regulation of all keratins is context-dependent and 
depends on the tissue type, stage of differentiation, homeostatic state, and disease 
(Moll et al., 1982; O’Guin et al., 1990; Fuchs, 1995; Freedberg et al., 2001). Cell 
fragility, decreased adhesion, barrier dysfunction, and inflammation are hallmarks 
of disrupted or forfeited keratin function (Smuth et al., 2001; Lane and McLean, 
2004; Segre, 2006; Arin et al., 2011, Coulombe and Lee, 2012). Keratins are 
involved in many diseases, likely due to their involvement in survival, death, 
motility, embryonic development, and cell growth (Pan et al., 2013).  This thesis 
focuses on a specific subset of keratins, K5 and K14, a Type II and Type I 























































centromere  ...  KRT222P   KRT24   KRT223P   KRT25   KRT26   KRT27   KRT28   KRT10   KRT12   KRT20   KRT23
KRT39   KRT40   KRT33A   KRT33B   KRT34   KRT31   KRT41P   KRT37   KRT38   KRT221P   KRT32   KRT35   KRT36  
KRT13   KRT15   KRT19   KRT9   KRT14   KRT16   KRT17   KRT42P   ...  telomere
  
Human chromosome 12q13.13:
centromere  ...  KRT80   KRT7   KRT121P   KRT122P   KRT81   KRT86   KRT23   KRT123P   KRT85   KRT84   KRT82
KRT124P   KRT75   KRT6B   KRT6C   KRT6A   KRT5   KRT71   KRT74   KRT72   KRT73   KRT125P   KRT2   KRT1 









Figure 1: (a) The keratin gene family and structure. Type I and type II keratins are 
shown. (Adapted from Coulombe, 2001). (c) Diagram of the keratin intermediate 
filament structure: The configuration, of all keratins intermediate filaments, is tripartite 
in nature, including a head, tail, and a central α-helical rod domain (Coulombe, 2001). 
(b) Electron microscopy image of in vitro purified K5 and K14 reconstructed filaments. 





Layers of the epidermis 
 
 Mammalian epidermis is a multilamellar arrangement of epithelial cells 
operating as a barrier between the inner body and the outside world. The epidermis 
is essential for survival; each of its layers can be recognized by unique 
characteristics and differences regarding permeability (Menon et al., 2012; 
Homalle 1853; and Dariau 1856). The epidermis is necessary for the maintenance 
of organismal homeostasis. It provides mechanical strength, prevents dehydration, 
and elicits immune responses guarding against microbes, irritants, allergens, UV 
radiation, pollutants, and chemical stressors.  
Classically, human epidermis is described as being comprised of four 
distinct layers or compartments: basal layer, spinous layer, granular layer, and 
stratum corneum (SC). The basal layer house progenitor, mitotically-active cells 
and express the keratin protein partners K5 and K14. Keratinocytes in the spinous 
layer are post-mitotic, have initiated the process of terminal differentiation and 
express the keratin protein partners K1 and K10 and, at a later stage, K2 (see 
Figure 2)	(Sadilands et al., 2009). While keratinocytes are differentiating, indeed, 
they move vertically in the epidermis from basal to suprabasal layers.  Following a 
series of morphological changes, keratinocyte differentiation concludes with the 
formation of a condensed, enucleated, non-living corneocyte in the SC layer (Elias, 
1983).   
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Stratum corneum: Major determinant of barrier function of the skin 
The physical barrier properties of the epidermis are mainly attributed to the 
SC (Blank, 1953). The SC is the outermost, terminally differentiated, non-living 
epidermal layer that is approximately 10-20µm and 25 cell layers thick (Smeden et 
al., 2014). The structure of the SC is often described as resembling a “brick in 
mortar,” with two principal constituents: the extracellular lipid matrix (the mortar) 
and the corneocytes (the bricks) (see Figure 3) (Elias, 1983). 
The SC lipids make up 10% of the SC volume and the extracellular lipid 
matrix is a major contributor to the skin barrier. The matrix fills extracellular 
spaces within the SC, limits water loss, prevents electrolyte imbalance, and 
contains antimicrobial properties (Elias et al., 2003; Feingold, 2008). The lipid 
composition of the SC is comprised of approximately 50% ceramides (9 types), 
Figure 2: Epidermal differentiation and layers of the epidermis. The layers of the 
epidermis are a result of proliferation and differentiation beginning at the basal cell.  
There is a variation in expression of associated proteins. The innermost layer of the 
epidermis is the basal layer and proceeding outward there is the spinous, granular, and 
the SC (or cornified layer) (Figures are adapted from Denecke et al., 2008 and 
Sadilands et al., 2009). 
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25% free fatty acids, and 15% cholesterols (Feingold, 2007; Grey et al., 1982; 
Wetz, 2006).  
Lipid precursors are contained in lamellar bodies, which are specialized 
organelles found in differentiated keratinocytes of the stratum granulosum layer, 
and are modified for SC consumption during keratinocyte differentiation (Elias 
and Friend, 1975). Lamellar bodies transport and in response to signals, such as 
increased calcium, release several substances into the SC including lipids, 
catabolic enzymes, IL-37, and human 𝛽-defensin 2 (Elias et al., 2014). Barrier 
disruption via topically-applied organic solvents (e.g., acetone) extracts lipids 
from the extracellular matrix and initiates a rapid homeostatic repair response 
resulting in expedited secretion of lamellar body products, a temporary decline in 
lamellar body numbers, followed by a swift assembly of new lamellar bodies 
(Menon et al., 1992).   
In addition to the extracellular lipid matrix, the other major component of 
the SC are the corneocytes, which are the end products of terminal differentiation 
where keratins align with a key matrix protein, filaggrin, and this interaction forms 
dense aggregate bundles (Proksch et al., 2008).  Within the corneocytes, there is 
a cornified envelope (CE) that is hardened, insoluble structure that is formed 
under the cell membrane (Denecker et. al., 2008) and serves as a support 
scaffold for the cell.  The CE is composed of many proteins, e.g.involucrin, 
loricrin, trichohyalin, and small proline-rich proteins.  A 5nm thick layer of lipids is 
covalently bonded to these proteins.  The proteins are cross-linked by disulfide 
bonds and isopeptide bonds formed by transglutaminases below the cytoplasmic 
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membrane (Candi et al., 2005; Smith et al., 2006). This union of keratin and 
filaggrin promote the breakdown of the keratinocyte architecture and morphology, 
producing the corneocyte’s distinctive squamous form (Proksch et al., 2008). 
 
  
Figure 3: Overall structure and function of the SC within the context of the 





K14 and Disulfide Bonding 
During the final stages of terminal differentiation, the formation of the CE 
and mitochondrial lipid composition are dependent on the stabilization of keratin 
intermediate filaments, which is aided by intermolecular disulfide bonding (Giroud 
and Leblond, 1951; Kumar et al., 2015; Matolsy and Matolsy, 1970). The 
functionality of the SC is highly dependent on the organization of corneocytes and 
the extracellular lipid matrix. Ergo, keratin 14 dependent disulfide bonding is likely 
an essential component of assembly and organization of the SC structure and skin 
barrier function. 
Previous studies have uncovered disulfide bonds in differentiation-specific 
keratins, e. g. K1 and K10, and K4 and K13 (Sun and Green, 1978; Steinert and 
Parry, 1993). Recently, the Coulombe laboratory reported the crystal structure of 
a human K14/K5 heterotypic complex (Lee et al., 2012). In the crystal lattice 
occurred a homotypic, trans-dimer disulfide bond involving a cysteine residue at 
position 367 (C367) in the central rod domain of K14 (see Figure 4b) (Lee et al., 
2012). The Coulombe lab showed that this particular disulfide bond does form in 
skin keratinocytes in vivo, where it contributes to the formation of a perinuclear 
network of keratin intermediate filaments, influencing nuclear shape and size (Lee 
et al., 2012).  Skin keratinocytes in primary culture and processed for the dual 
staining of K14 and disulfide-bonding uncovered their spatial coincidence in the 
perinuclear area following calcium-induced differentiation, (Lee et al., 2012).  
Propelling the significance of keratin-dependent disulfide bonding, live cell 
imaging of cultured keratinocytes and the monitoring of keratin filament dynamics 
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revealed that, unlike wild type (WT), K14 cysteine-free variants failed to form a 
concentrated perinuclear IF network when expressed in a K14 null setting (Feng 
et al., 2015).  Feng (2015) also noted enhanced nuclear movement in GFP-K14CF-
expressing keratinocytes (CF, cysteine-free). However, when a single cysteine, 
namely C367, is reintroduced into the GFP-K14CF backbone, a significant portion 
of the aberrant phenotype is ameliorated (Feng 2015). This finding is significant, 
as there are five cysteine residues in human K14 protein located at positions: 4, 
18, 40, 367, and 389 (see Figure 4a) (Lee et al., 2012). Their body of work 
demonstrated that K14 disulfide bonding is an important regulator of assembly, 
organization, and dynamics for KIFs, with emphasis on the importance of C367’s 
contribution (see Figure 4c) (Lee et al., 2012; Feng et al., 2015). The findings of 
Lee and Feng have led to curiosity regarding the significance of C367 in K14 in an 











Figure 4: K14 intermediate filament structure, heterodimer, and involvement 
in keratinocyte differentiation. (a) The configuration, of all keratins intermediate 
filaments, is tripartite in nature, including a head, tail, and a central α-helical rod 
domain. (b)Diagram of K14/K5 heterodimer and trans-dimer disulfide bond. (c) 
Model of the role of keratin disulfide bonding in differentiating keratinocytes 






Assembly of the SC 
Normal CE assembly occurs in multiple layers of the epidermis, in three 
key stages: initiation, the formation of the lipid envelope, and reinforcement (see 
Figure 5) (Kalinin et al., 2001).  Initiation of CE assembly occurs in a calcium- 
and differentiation-dependent manner (Kalinin et al., 2001).  First, envoplakin and 
periplakin are expressed, generating heterotetramers, which then associate with 
involucrin and the plasma membrane (Kalinin et al., 2001). Afterward, the 
enzyme transglutaminase 1 facilitates the linkage of plakins and involucrin 
constructing isopeptide crosslinks that merge with desmosomal proteins (Kalinin 
et al., 2001). These crosslinks eventually traverse the entire, inner plasma 
membrane surface, while altering the properties of cell junctions and cytoskeletal 
interactions (Kalinin et al., 2001).  
Next, the formation of the CLE occurs as the golgi complex sprouts 
lamellar bodies in the granular layer of the epidermis (Kalinin et al., 2001). 
Lamellar bodies produce specialized lipids with 𝛚-hydroxy-ceramides with long 
fatty acid chains (cholesterol, free fatty acids, esters, and ceramides) that are 
delivered to the plasma membrane surface for extracellular distribution at the 
granular and cornified layers (Kelinin et al., 2001).  These long fatty acid chains 
are covalently esterified by transglutaminase 1, onto scaffold proteins assembled 
during the initiation stage, replacing the plasma membrane, allowing interactions 
with the extracellular lipid matrix (Kalinin et al., 2001).   
Reinforcement, the last stage, requires loricrin and small proline-rich 
proteins (SPRP), which constitute 80% of the cornified cell envelope (Kelinin et 
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al., 2008). The SPRPs and loricrin are crosslinked by transglutaminase 3 forming 
homodimers and heterodimers that are dispatched to the cell periphery (Kelinin 
et al., 2008). At the cell border, transglutaminase 1 crosslinks these proteins, 
fortifying the current framework. Furthermore, other proteins such as repetin, 
trichohyalin, cystatin, alpha, LEP/XP-5 proteins make minor contributions. 
(Kelinin et al., 2001). As reinforcement proceeds, other cell structures (e.g. 
desmosomes, microfilaments, organelles, microtubules) are destroyed. 
Considering intermediate filament contribution, when assembly is complete, K1, 
K2e, and K10 dwarf all other Ifs and are bound to residual desmoplakin, 
envoplakin, loricrin, involucrin, and SPRS (Kelinin et al., 2001). At the end of CE 
assembly, the dead corneocytes, consisting mostly of water and microfibrillar 




Skin barrier analysis of the Krt14C373A mouse model 
 
The culmination of previous reports in our laboratory (by Chang-Hun Lee, 
Xia Feng, and Yajuan Guo) led us to hypothesize that the mutant mouse model 
K14C373A would exhibit skin barrier defects. Ultimately, Lee discovered the 
crystal structure of the human K5/K14 heterodimer, which includes a homotypic, 
trans-dimer disulfide bond at position 367 in K14. Feng revealed the importance 
of the C367 (orthologous to 373) on keratin network organization, assembly, and 
Figure 5: The stages of CE assembly. This schematic representation of CE assembly 
begins with (1) initiation, followed by (2) creations of CLE, and then (3) reinforcement 
(Kalinin et al 2001). 
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dynamics.  Yajuan Guo utilized the CRISPR/Cas9 to generate a Krt14C373A 
knock-in mice, in which the cysteine resides at position 373 was replaced with an 
alanine (C373A). Residue C373 in mouse K14 protein is orthologous to human 
C367.  Guo showed that there is a decreased level of disulfide-bonded K14 
species in the skin of Krt14C373A mice, with the overall levels of K14 remain 
normal. In studying these mice, Guo also found altered localization of 
keratinocyte differentiation markers (K14 and K10), decreased tight and 
adherens junction signals in immunofluorescence (ZO-1 and Claudin-3), and 
decreased filaggrin expression.  Filaggrin and its precursor profilaggrin are key 
contributors to barrier homeostasis. Filaggrin overexpression or profilaggrin loss 
results in barrier irregularities, e.g. ichthyosis vulgaris and atopic dermatitis 
(eczema) in the human population disease (Proksch et al., 2008). This mouse 
model allows for comparative analysis of barrier structure, function, and 
homeostatic repair response in the postnatal and adult stages between WT and 
K14C373A mutant mice, which would enable us to elucidate the role of one 
disulfide bonded K14 in skin barrier function. 
 The present study uses a Krt14C373A mouse model for an initial 
characterization of SC structure and barrier function. In this mouse strain, the 
Crispr-Cas9 technology was used to replace cysteine residue 373 with an alanine 
(C373A) in mouse K14 (Yajuan Guo, unpublished data). The Krt14C373A mouse 
was evaluated under two conditions: 1) at baseline and 2) following topical 
treatment with acetone, an organic solvent known to disrupt the barrier. The central 
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hypothesis being tested is that barrier function is disrupted and its homeostasis 
perturbed in the Krt14C373A mouse. 
We examined barrier activity at three stages: embryonic development, 
postnatal barrier function, and adult barrier function using a toluidine blue dye 
penetration assay and via measurements of trans-epidermal water loss using a 
Tewameter TM-300. These measures are commonly used to assess barrier 
function in rodents and humans since higher degrees of evaporation are 
associated with decreased barrier function.  Skin barrier development occurs late 
in gestation in an established pattern, concurrent with the final stages of CE 
construction, which can be assessed by toluidine dye exclusion (Graubauer et al., 
1989; Hardman et al., 1998).  
TEWL is often used a signal for barrier recovery (Grubauer et al., 1989). 
Measurements of trans-epidermal water loss using a Tewameter have been 
validated in both humans and rodents as an accurate metric of barrier homeostasis 
(Fluhr et al., 2006).  For example, in humans, increased in TEWL at the first 2 days 
of birth, and 3 months is an adequate predictor of atopic dermatitis at 1 year 
(Kelleher et al., 2015).  
Measurements of SC permeability are not only important for water egress, 
but also the penetrance of pathogens, chemicals, irritants, pollutants, and 
allergens. To assess the SC morphology, we examined the two major components 
of the SC, lipid abundance and CEs. To determine barrier function in regards to 
immunity and barrier homeostasis, we examined cytokine transcripts of DAMPS, 
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which are present in the epidermis to initiate immune response in the event of a 
barrier breach (Chan et al., 2012).  
Materials and Methods 
 
Animals 
The Krt14C373A mice were generated by Yajuan Guo (Coulombe 
laboratory) in collaboration with Dr. Vinod Ranganathan (Department of 
Ophthalmology) and the Johns Hopkins Transgenic Core. WT and Krt14C373A 
mice (C57BL/6 strain background) were maintained under specific pathogen-free 
conditions and fed rodent chow and water ad libitum post weaning. At 2-3 months 
of age mice were considered “adults”. All procedures involving mice were 
performed using protocols reviewed and approved by the Johns Hopkins 
University Animal Care and Use Committee under protocol number M016H340.  
Genotyping was performed using a standard protocol and the primers listed 




Target Primer Sequence (5'-->3')  
Krt14 Forward 5’-AGACCAAAGGCCGTTACTG-3’ 
Krt14 Reverse 5’-ATTCCAGGCCCAGGTTTGAG-3’ 
SRY Forward 5’-TTGTCTAGAGAGCATGGAGGGCCATGTAA-3’ 
SRY Reverse 5’-CCACTCCTCTGTGACACTTTAGCCCTCCGA-3’ 
Krt14373A Forward 5’-ACCAAAGGCCGTTACGC-3’ 
Krt14373A Reverse 5’-TTGAGGTGGAGGAGGAGTCT-3’ 
Table 1: Above are the forward and reverse sequences of mouse primers used in to 
genotype embryonic, postnatal, and adult mice. 
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Mouse Studies 
Topical acetone treatments of Krt14C373A mice 
The ears of adult age-matched male WT and Krt14C373A mice were 
topically treated with 40µl of acetone twice daily for 7 days (see Figure 6).  The 
volume of acetone was split equally between the dorsal and ventral sides of the 
ear. One ear was left untreated as a control. Anesthesia was administered 
according to IACUC standards. After treatment mice were killed and tissue was 
harvested for analysis.  
 
TEWL Measurements 
TEWL measurements were performed using a TEWAMETER TM-300 
(Mecco, Warrington, PA USA) open chamber probe. The TEWL of ears of adult 
Krt14C373A and WT mice were measured at baseline and following acetone 
treatment regimen (treated and untreated ear) at 0, 6, 24, 48, 72, 96, and 120 
Figure 6: Experimental scheme of 7 day Acetone treatment.  Male mice were 
treated twice per day for 7 days with 20µl of acetone on the dorsal ear and 20µl on the 
ventral left ear. The right ear received no treatment and was used as a control. The 
tissue was harvested immediately following the last acetone treatment on day 7. 
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hours following the last treatment of acetone (see Figure 7).  During the TEWL 
measurements adult mice were anesthetized. Measurements were taken on the 
dorsal ear only. The probe was warmed for approximately 2 minutes between each 
measurement.  The mouse was placed on its side on a napkin and the ear was 
flattened using toothless forceps with light pressure. The TEWL was held in place 
for a minimum of 30 measurements and until the alpha level was below 0.2. Since 
it is an open chamber device, the appropriate location of the ear was verified 
visually.  
 The TEWL of untreated dorsal lower back of postnatal pups (P0.5-P4) of 
Krt14C373A and WT mice were measured.  The dorsal lower back (just above the 
tail) was chosen because the ear is inaccessible at these ages. TEWL 
measurements were performed while the pups were conscious.  Measurements 
are sensitive to movement; therefore, pups were allowed to acclimate for 5 
minutes.   
Figure 7: Experimental design for acetone treatment with TEWL measurement 
timeline. This experiment followed the original acetone design using adult male mice, 
age 2-3 months, However, this protocol includes an additional step, TEWL 
measurements at the above time intervals. 
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Toluidine blue dye skin permeability assay 
A standard toluidine barrier function assay was performed on E16.5 and 
E17.5 WT and Krt14C373A following a standard protocol (DiTomasso and Foijer, 
2014; Hardman et al., 1998.).  Briefly, mouse embryos were dehydrated at 4°C in 
water-based baths with ascending then descending methanol concentrations of 2 
min: 25%, 50%, 75%, 100%, 75%, 50%, 25%, 0%. The embryos were then 
washed in PBS (pH7.4) and stained with 0.1% toluidine blue for 1-2 minutes on 
ice. Pups were then washed 4 times in 50mL tubes of PBS (pH 7.4) to destain 
the embryos.  We verified the genotype and sex of each pup.    
Biochemical and morphological analysis 




























For routine histology, ear tissue of adult Krt14C373A and WT mice treated 
with acetone or untreated were fixed in formal saline and embedded in paraffin.  
Sections (5µm) were fixed overnight stained with hematoxylin and eosin by JHU 
pathology core services following standard protocols.   
Target Primer Sequence 
































Table 2: List of Targets and qRT-PCR Primers used. 
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For immunofluorescence Lipidtox staining a standard protocol was used 
(Fasta et al., 2011).  Ear tissue of adult Krt14C373A and WT mice treated with 
acetone or untreated were embedded in OCT (VWR, Radnor, PA) and frozen using 
dry ice then sectioned at 15µm then thawed at RT 30 min following removal from 
a -20°C freezer. Tissue was fixed in 10% fresh formalin (diluted from 37% 
formaldehyde) for 10 minutes.  Light was avoided during fixation step. Tissue was 
then washed with PBS three times. HSC Lipidtox- red neutral lipid (Invitrogen by 
Thermo Fisher Scientific) was diluted in PBS 1:200 and applied to the specimens.  
The tissue was incubated for 30 min at RT. The specimens were washed once in 
PBS for five minutes. DAPI was diluted 1:5000 in PBS and applied to specimens, 
which were then incubated for ten minutes at RT followed by three additional 
washes with PBS for 5 minutes each. Each slide was mounted using FluorSave.  
 
Isolation, extraction, and preparation of cornified envelopes (CEs)  
CEs were isolated from dorsal ear tissue and tail tissue from age-matched 
male WT and Krt14C373A mice. To separate dorsal from ventral ear tissue, we 
followed the Murine Skin Tissue Transplant protocol for ear tissue separation (the 
JOVE surgical video is available:  https://www.jove.com/video/634/murine-skin-
transplantation (removal of balbC donor skin video) (Gerod et al., 2008). Next, the 
epidermis was extracted using a protocol described by Roth et al. (2009) (see 
appendix). For extraction and preparation of CEs, a modified Wera Roth 2010 
protocol (see appendix). Adult mouse ear skin or adult mouse tail skin (1cm in 
length) were boiled at 95° C (in place of hot water bath) for 20 min in 2ml CE 
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isolation buffer containing 20 mM Tris-HCl (pH 7.5), 5 mM EDTA, 10 mM 
dithiothreitol (DTT), and 2% sodium dodecyl sulfate (SDS). Half of the extracted 
sample (1ml) was flash frozen and stored for future studies.  CEs were extracted 
from the remaining (1ml) of the CE isolate. Samples were centrifuged for 5-minutes 
at 5,000 × g rinsed in CE isolation buffer with 0.2% SDS, re-pelleted, re-suspended 
in 250 µl the washing buffer, and stored at 4°C until seeded.   
For morphological evaluation, the CE isolates of dorsal ear and tail were seeded 
on a glass slide at a concentration of 1.5 x 106 CEs and 6 x 106 CEs, respectively, 
and covered.  CE were isolated from at least 4 mice per genotype. 
 
Microscopic imaging of cell and tissue preparation  
For immunofluorescence staining, all images were obtained using an 
inverted Zeiss microscope (Thornwood, NY) fluorescence microscope with 
Apotome attachment and further processed using Adobe Photoshop CS2.  For 
CE isolates, imaging and concentration calculations was completed within 48 
hours of seeding and obtained using a phase contrast Zeiss microscope at 10x 
and 20x (Phase II) at room temperature.  For toluidine blue treated embryos, 
images were obtained using a digital camera, a Canon RebelT5 EOS 1200D.   
 
Quantification of images 
Initial qualitative observations were made using criteria to distinguish CE 
as normal or abnormal.  For an initial blinded assessment of CE structure, we 
categorized CE as abnormal if: CE size is reduced by 50%, altered aspect ratio, 
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and decreased phase contrast. A mean percentage of CE normal & abnormal 
was calculated following the examination of one hundred CE, from four 
individuals of the same genotype, for a total of 400 CE analyzed for each 
genotype (see figure 9). 
A blind analysis of the CE images was completed manually using the 
ImageJ software and a Wacom Intuous Pro drawing pad, followed by an 
automated macros analysis written by Dr. Ritankar Majumdar at the NIH.  A 
manual cell count was performed for the quantification of CE fragility. Additionally, 
lines were hand drawn to trace and measure the aspect ratio, circumference, and 
area of at least 100 CEs.  Four biological replicates per genotype were examined, 
and 10-20 images of different regions the slides were obtained per mouse and 
images were further processed using Adobe Photoshop CS2. Lipidtox 
intensity was also measured using ImageJ (NIH).   
For the toluidine blue assay, the pups were analyzed based on a 0-10 scale, 
where 0 represents 0% staining, and 10 represents 100% staining.  These scores 
were averaged and compared across genotypes.  
 
Statistical Analysis 
Statistical analysis was performed using Prism Graphpad7, and a 
standard t-test and F-test was used to analyze CE and TEWL data.  A 2-way 
analysis of variance (ANOVA) and individual t-tests were used to compare TEWL 
for the 7-day acetone barrier recovery experiment since more than 3 groups were 
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involved. F-tests were used to determine variance among populations.  Statistical 





TEWL at baseline conditions reveals a distinct phenotype in Krt14C373A 
vs. WT adult mice. 
 
  The ear skin of young adult (2-3 months old) mice homozygous for the 
Krt14C373A mutation have a statistically significant increase in baseline TEWL, 
by 178%, in comparison to WT controls (11.32±0.89 g/m2/h vs. 4.07±0.44 g/m2/h; 
p<0.0001) (see Figure 9). There were no statistically significant differences 
among WT female and male control mice (4.32 g/m2/h±0.43 vs. 3.81±0.78 
g/m2/h; p=0.575). Female Krt14C373A mutant mice have a significantly greater 
TEWL than their mutant male constituents with a mean TEWL that is 37.8% 
higher (13.42 g/ m2/h±1.11 vs. 9.75 ±1.04 g/ m2/h where p=0.0366). Mutant 
females were higher than their WT female counterparts by 211% (13.42±1.11 g/ 
m2/h vs. 4.32±0.433 g/m2/h where p<0.0001). When stratified according to sex, 
Krt14C373A mutant mice exhibited significantly higher TEWL measurements 





Figure 8: TEWL measurements for WT and Krt14C373A adult mice.  TEWL 
measurements revealed a significant increase in TEWL for mutants in comparison to 
WT(above). This difference is maintained when stratified according to sex (below). 
Krt14C373A females display higher TEWL than their Krt14C373A male constituents.  
NWT=24 and NMUT=21 (units are in g/m2/h).   TEWL results stratified by sex (units are in 





















































Histological analysis reveals alterations in Krt14C373A mutant mouse 
epidermis at baseline 
 
 No macroscopic lesions could be detected in intact skin of Krt14C373A mice 
(data not shown). Tissue processing for histological examination via light 
microscopy revealed a modest thickening of the epidermis, along with evidence of 
hyperkeratosis (see Figure 9). These observations confirmed the previous findings 







Figure 9: Histology of untreated Krt14C373A and WT epidermis. Histological 
findings indicate hyperproliferation and hyperkeratosis are present in the Krt14C373A 





Krt14C373A mutation causes abnormal CE morphology 
Analysis of CEs obtained from mice carrying the Krt14C373A mutation and WT 
controls was carried out using phase contrast microscopy. WT CE were mostly 
oval in shape with smooth outlines. Additionally, the WT CEs appeared relatively 
uniform in size and shape. By contrast, CEs harvested from Krt14C373A skin 
appeared jagged, less oval-shaped, with irregular, undulating borders (see Figure 
10).  
Qualitative and quantitative analyses were performed in a blinded fashion 
on images of CEs obtained from K14C373A and WT ear and tail skin. This 
revealed significant departures from WT CE morphology in mutant skin (see Figure 
11 and 12).  Quantitative analyses of CE images using ImageJ software confirmed 
these findings. Approximately 100 measurements of CEs were taken from the 
images obtained for four WT and four mutant mice. 
Overall, qualitative analysis (normal appearing vs. abnormal appearing) 
revealed a higher mean percentage of abnormal CEs in dorsal ear epidermis from 
Krt14C373A mutant mice relative to controls (44.0% ± 3.16 vs. 16.5% ± 2.95; 
p=0.0007). Furthermore, the tail epidermis Krt14C373A mutant mice also had a 
higher percentage of abnormal CEs (55.5% ± 3.6 vs. 31.25% ± 2.17; p=0.0006), 
as shown in Figure 11. Quantitative analysis revealed an increased aspect ratio, 
lower contrast, decreased circumference, and decreased surface area or size for 
the mutant CEs (see Figure 12).  
CEs from tail skin of Krt14C373A and WT mice exhibited differences that 
were similar to detected in ear skin. The mean aspect ratio of mutant CEs was 
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increased by 11% relative to WT (1.39±0.02 vs. 1.25±0.01; p<0.0001). F-test 
revealed variance of tail aspect ratio between populations was significant (F=2.652 
and p<0.0001). The mean circumference of mutant CE was decreased by 8% 
relative to WT (132.5.0±1.037 μm vs. 142.9±1.042 μm p<0.0001). Finally, the 
mean area of mutant CEs was smaller by 8% relative to WT control (32.58±0.279 
μm2 vs. 35.4±0.269 μm2; p<0.0001; see Figure 12). Variance between populations 
were not statistically significant regarding tail area or circumference (F= 1.017 and 
1.118; p=0.2526 and p=0.8610). 
 The CE from ear tissue displayed similar differences. The CE mean aspect 
ratio of Krt14C373A mutant mice was increased by 32% and was considered to be 
statistically significant relative to WT, (1.317± 0.01671 vs. 1.213±0.01054; 
p<0.0001). F-test revealed variance of ear aspect ratio between populations was 
significant (F= 2.447 and p<0.0001.) The differences measured in mean surface 
area of Krt14C373A mutant were not statistically significant (29.22 ±0.42159 μm2 
vs. 29.25±0.1796 μm2) (p = 0.9237). Mean CE circumference was smaller for 
mutant mouse relative to WT, by 4% (117.6±0.8704 μm vs. 122.3±0.6341 μm 
where p<0.0001; see Figure 12). Variance between populations was also 
statistically significant regarding area and circumference (F=1.412 and 1.848 





Figure 10: Morphology of WT and Krt14C373A CE extracted from mouse tail and 
ear epidermis. The top row shows CE from tail epidermis of WT and mutant adult male 
tissue at approximately 3 months of age (20x magnification). The bottom row shows CE 
from ear epidermis of WT and Krt14C373A adult male tissue at approximately 3 months 
of age (10x magnification).  Mutant CEs appear to have abnormal morphology regarding 
size and shape. Krt14C373A mutant CEs appear jagged, less oval-shaped, with 









Figure 11: Mean percentage of abnormal CEs from WT and Krt14C373A. 
derived from ear and tail SC. Mutant CE has a significant increase in the mean 
percentage of CE that appear to be abnormal (N=4, 100 CEs were examined per 








































































































































Figure 12: Quantitative Analysis of CE Morphology in Ear and Tail epidermis to 
display mean differences.  Left column displays CE morphological analyses. 
Krt14C373A Tail CEs have an increased mean aspect ratio, decreased mean 
circumference, and decreased mean area relative to WT. Right column displays CE 
morphological analyses.  Mutant Ear CE has increased aspect ratio, decreased 
circumference and an area that is similar when compared to the WT. Error bars 
represent SEM. Asterisks denote statistical significance. (N=4, 100CEs were 





Acetone treatment results in increased SC fragility and morphological 
anomalies in Krt14C373A mutant epidermis 
 
Histological analysis following a 7-day course of topical acetone-mediated 
barrier disruption resulted in mildly increased thickness of the living layers of the 
epidermis in WT mouse ear skin (N=3).  Acetone treatment resulted in 
substantial disruption of the SC in Krt14C373A mutant ear skin, but not WT (see 
Figure 14).  Compared with untreated Krt14C373A mutant ear skin (see Figure 












Figure 13: Histology of WT and Krt14C373A following 7-day acetone exposure. 
Findings indicate that the mutant epidermis is more fragile than WT. SC disruption is 









Krt14C373A mutations result in lipid loss within the SC.  
Immunofluorescence (IF) examination revealed a similar distribution of 
lipids in mutant and WT ear skin at baseline (N=2). After a 7-day course of 
acetone treatment to both side of the ears skin, however, the Lipidtox signal was 
decreased in the SC layers of mutant relative to WT skin (see Figure 14). The 
average signal intensity for WT and Krt14C373A lipid staining without treatment 
was found to be 31.98 and 26.84 on average. Therefore, at baseline mutants 
experiences a % decrease in lipid abundance relative to WT. 
 Following the application of acetone, the relative signal intensities 
decrease for both genotypes, with WT at 14.24 and Krt14C373A at 7.96.  
However, mutant mice experienced a 44% decrease in immunofluorescence 
signal following acetone treatment in comparison to WT following acetone 
treatment. Statistical significance was not calculated for this assay due to low 







Figure 14: Immunofluorescence-based imaging for neutral lipids in mouse ear 
stratum corneum. LipidTOX signal intensity (red) reveals differences following treatment in 
WT and Krt14C373A following acetone treatment. Arrow depict areas of stratum corneum 






































K14C373A experiences hyper-activation of DAMPS 
 Mutant transcript levels of DAMPs are elevated following acetone 
treatment. The mRNA levels for DAMP-encoding genes were significantly 
elevated for several DAMPs: S100A1, S100A2, S100A7, S100A8, S100A10, IL1-	
β, HMGB1, and DEFB3.  The level of S100A8, S100A9, S100A10, IL-1	β, and 
HMCB1 experienced impressive increases of transcript levels with an average 




Figure 15:  Fold changes in damage associated molecular patterns (DAMPs) in WT and 
K14C373A Mice following acetone treatment as compared to WT untreated. Asterisks 

























S100A1 2.4 7.8 0.00769* 
S100A2 3.7 10.5 0.00079* 
S100A7 2.1 4.6 0.014786* 
S100A8 4.46 14.6 0.013198* 
S100A9 9.8 27.33 0.007421* 
S100A10 10.7 19.6 0.000564* 
IL1 A 1.87 3.5 0.083547 
IL1- β 1.3 49.6 0.002986* 
HMGB1 1.1 11.9 0.006162* 
DEFB3 1.43 2.4 0.037618* 
TSLP 1.23 2.4 0.264882 
HSP b1 1 1.23 0.503762 
HSP8 1.13 1.36 0.413679 
Sprr 2d 1.133.5 2.03 0.424959 
Sprr 3 1.04 3.03 0.243759 
 
Table 5: Transcript level changes in found in DAMPS.  Statistical significance is 
indicated by asterisks. 
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Barrier disruption via acetone results in an increased TEWL Krt14C373A 
mutant mice relative to control.  
 
The homeostatic barrier repair response, in WT mice vs. Krt14C373A) was 
elevated and statistically significant for the first four measured time points (t-test 
values: P1=0.001, P2=0.009, P3=0.03, P4=0.004). WT controls treated with acetone 
for 7 days (twice per day) have a higher increase in TEWL that returns to baseline 
TEWL within approximately 72 hours. Krt14C373A mutant mice have an 
attenuated barrier response which returns to mutant baseline at approximately 120 
hours following acetone treatment, which is expected considering the heightened 




 Figure 16: TEWL barrier recovery following acetone treatment in WT and Krt14C373A 
(Left) TEWL values of acetone treated ear Krt14C373A versus WT revealed significant 
increases in TEWL following acetone treatment in the Krt14C373A mutants suggesting 
increased sensitivity 120 hours after barrier disruption when compared to the WT. A 2-way 
ANOVA was performed and the differences were found to be statistically significant, 
p<0.0001.  (Right) Mean difference in TEWL measurements were calculated as follows 
[mutant acetone treatment- mutant control] vs [WT acetone treatment- WT control] (N=6). 
 























































TEWL at baseline conditions does not reveal a distinct phenotype in 




TEWL and weight was measured for WT and mutant postnatal pups at 
after birth at postnatal 0.5, 1, and 4 days. These analyses revealed no 
statistically significant differences between WT and mutant mice (see Figure 17). 
Additionally, no difference was seen when stratifying the pups according to sex 





















































Table 4:  Mean TEWL and mean weight for postnatal pups P0.5-P4 in WT and 











































































































Figure 17: Mean TEWL and Weight for postnatal pups in WT and Krt14C373A.  Row 1 
shows P0.5. Row 2 shows P1. Row 3 shows P4. No statistically significant differences were 
found among groups observed concerning weight and TEWL. For P0.5 NWT=11, NHET=12, 
NMUT=27. For P=1 the NWT=10, NHET=15, NMUT=5.  For P=4 the NWT=10, NHET=6, NMUT=14. 
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Figure 18: Embryonic barrier formation of WT and Krt14C373A observed via 
toluidine blue staining in E17.5 pups. One observed staining pattern displayed by an 
~E17.5 litter stained with toluidine and scoring is displayed above. No obvious patterns 
in embryonic barrier formation was determined.   
Heterozygous 
Male 




WT Female  Mutant 
Female  
Toluidine Blue Assay reveals no significant differences in barrier 
development in embryonic Krt14C373A mice  
 
 
A toluidine blue dye exclusion assay was used to assess the barrier status 
in late stage mouse embryos (E17.5) since epidermis matures by E16.5 and 
development of the barrier occurs during this stage of development. Due to the 
sensitivity of this assay, coupled with the rapid time course of maturation of the 
skin barrier at approximately E16.5 during mouse development in utero, pups 
within the same litter were selected for comparison. We were unable to 
determine conclusively if the K14C373A mutation has any impact on skin barrier 








  E17.5 Litter (N-6) 
Genotype Mean Score (N) 
MUT 5.167 N=3 
HET 5.50 N=1 




It is widely accepted that changes in keratins, CE structure, and lipid 
composition, cause barrier function impairment (Ruether et al., 2006).  Although 
K14 is primarily expressed in the basal layer, it is a long-lived protein that is 
present in multiple layers of the epidermis (Lizuka, 1994; Noval and Nickerson 
1958; Weinstein and Scott, 1965).  Studies of epithelial cell lines with RNAi-
mediated K14 knockdown support the notion that K14/K5 act as negative 
regulators of cell differentiation (Alam et al.,2010).  Keratin disulfide bonds are 
major contributors to the resistance of enzymatic disassembly due to its role in 
stereochemical configuration stabilization (Alexander and Hudson, 1954). Thus, it 
is conceivable that alterations in K14-dependent disulfide bonding may modulate 
the terminal differentiation of keratinocytes and subsequently barrier function.  
This study was completed to elucidate the role of K14-dependent disulfide 
bonding in skin barrier function in vivo, using the Krt14C373A mouse model 
created by Yajuan Guo.  In this mouse K14-dependent disulfide boding is 
reduced and altered in skin tissue, as shown by biochemical analyses, owing to 
the replacement of cysteine residue 373 by alanine in K14.  Moreover, 
abnormalities were identified in several key elements as part of the barrier 
dysfunction phenotype in Krt14C373A, e.g. increased epidermal proliferation, 
disturbed differentiation, and anomalies involving involucrin, loricrin, and filaggrin, 
three key CE constituents which influence barrier function.   
We hypothesized that K14-dependent disulfide-bonding is important for 
maintaining barrier homeostasis and challenged the Krt14C373A mice with an 
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environmental stressor that induces a skin barrier breach. Consistent with 
previous findings, there is a positive correlation between barrier function and 
disulfide bonding. Through comparisons involving TEWL, CE morphology, lipid 
abundance, and cytokine expression profiles between Krt14C373A and WT 
controls, we established that the modification of a single amino acid at position 
373 affects skin barrier homeostasis. An elevated response in TEWL and 
decreased lipid abundance was noted in our mutant mice when chemically 
challenged with acetone in addition to enhanced protective immune response, 
providing evidence that strongly support our hypothesis.  Taken together, these 
findings suggest that key morphological aspects of the barrier and the 
physiologic function of Krt14C373A mutant mouse skin are distinct from WT 
mice.   
Even modest alterations found in individual CE, such as those found in our 
mutant mice, may have a cumulative effect, leading to a major consequence 
concerning the organization of the diffusion pathways. Potts and Francoeur 
(1991) established that CEs are partially responsible for lipid organization. They 
claim that SC permeability is 1000 times lower than values obtained for most 
other lipid membranes, due to the inclusion of CEs (1991). In essence, the lipid 
extracellular matrix allows limited fluid passage, whereas the corneocytes act as 
absolute barriers that must be circumnavigated. Thus, even the mild variations 
from a more uniform CE morphology that we observed in Krt14C373A may act by 
decreasing the tortuous nature of fluid movement through extracellular matrix of 
the SC, ultimately increasing the rate of evaporation from the epidermis.  
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 In addition to CE abnormalities, mutant mouse skin features substantially 
reduced amount of SC lipids after barrier challenge with topical acetone and 
absolute lipid concentrations represent a crucial determinant of skin barrier 
function. Lipids contribute to the extracellular matrix and have complementary 
roles in addition to water regulation in the SC. Cholesterol sulfate, which is found 
in abundance in the SC, has a cohesive function that is relevant to desquamation 
(Elias et al., 1984; Williams and Elias 2014).  Free fatty acids alter the pH of the 
SC layer, creating an acidic environment (pH 5-5.5), and pH changes can 
influence protease activity, and thus desquamation (Fluhr et al., 2004; Fluhr et 
al., 2001; Mauro, 2006).  Phospholipase is a pH-sensitive enzyme and it 
produces glycerol which acts as a water holding agent which is significant since 
hydration provide signals that regulate epidermal DNA synthesis and influence 
inflammation (Denda et al., 1998a; Denda et al., 1998b; Scott and Harding, 
1986).   Lipid composition also significantly affects the skin barrier; when topical 
lipid mixtures are frequently applied an excess or deficiency of any individual lipid 
group result in an abnormal SC extracellular lipid matrix formation (Feingold, et 
al., 1991; Menon et al., 1992).  Additionally, the lipids of the extracellular lipid 
matrix house proteolytic enzymes, proteolytic inhibitors, ß-defensin, cathelicidin, 
LL-37, and corneodesmosin (Elias, 2012). Thus, lipids are an essential 
component of the SC participating in both homeostasis and repair and the 
exaggerated lipid loss experienced by our mutant mice, within the SC, 
contributes to increase in trans-epidermal water loss and irregular function. 
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The assessment of DAMP levels following acetone treatment revealed 
hyperactivation in the Krt14C373A mice not seen in WT mice.  DAMPS are 
recognized as a contributor to many diseases such as tumorigenesis, metastasis 
of cancer, autoimmune and inflammatory diseases (Chan et al., 2012). 
Numerous studies have uncovered that SC function is linked to the pathogenesis 
of multiple inflammatory skin disorders, such as atopic dermatitis, contact 
dermatitis, and psoriasis (Man et al., 2015). At some point in the future, the 
Krt14C373A mutant mouse strain should be assessed in terms of its 
susceptibility to tumorigenesis, autoimmune, or inflammatory conditions. 
The physiologic assessments of TEWL also yielded interesting results. In 
postnatal pup epidermis revealed no significant differences in dorsal back skin of 
WT and Krt14C373A.  This is consistent with the observations of Yajuan Guo, 
who observed no differences in disulfide bonded K14 in keratinocytes isolated 
from newborn back skin in WT versus Krt14C373A.   In contrast, TEWL 
measurements in adult ear tissue revealed that adult Krt14C373A mutant mice 
have higher rates of TEWL in comparison to WT mice. This may be due to 
tissue-specific differences. For example, Quigley et al.  performed an analysis of 
genetic architecture in adult mice examining specific cell types and signaling 
pathways (e.g. sonic hedgehog (Shh), Wnt, Lgr family, stem cell markers, and 
keratins) to monitor the effects of germline variation, skin tissue location, 
exogenous inflammation, or tumorigenesis (2016). Tissue locations, e.g., dorsal 
and tail skin, displayed significant differences among keratin gene networks and 
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differential cancer susceptibility, suggesting skin diseases are dependent on 
these conserved gene networks and their mechanisms (Quigley et al., 2016).  
 No obvious differences were observed in the rate of TEWL barrier 
recovery between WT and Krt14C373A when challenged with acetone.  The 
additional time required for recovery in Krt14C373A is likely due to increased 
barrier disruption and not altered rates of barrier repair. Similarly, other studies 
concerning barrier recovery rate have revealed no differences in barrier rate 
including studies of loss of filaggrin-related to atopic dermatitis, where distinct 
phenotypes in barrier integrity and function are revealed when patients following 
tape-stripping challenges (Fischer et al., 2011).  This data does not suggest any 
disparity in the rate of barrier repair, however more research must be completed 
to obtain conclusive data on barrier repair kinetics. Additionally, the TEWL 
findings uncovered a distinct sex difference in adult mice when the data is 
stratified, with higher TEWL scores belonging to the female mice.   
On the subject of barrier function and sex, it has been shown that male rat 
fetuses develop barrier slower than females because testosterone delays 
development of the cutaneous barrier (Hanley et al., 1997). Conversely, estrogen 
supplements in vitro accelerate the formation of the epidermal barrier, and sex 
differences during barrier development in vivo is moderated by testosterone (Kao 
et al., 2001). Embryonic toluidine blue assays revealed no statistically significant 
differences between WT and Krt14C373A. Furthermore, no differences were 
detected in postnatal TEWL or weight. 
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 It is likely that embryonic barrier formation and postnatal pup homeostasis 
is affected by k14 dependent disulfide bonding, however, the observations of 
embryonic and postnatal pups, were limited by several factors. Small litter sizes, 
coarse approximations of age, and sexually dimorphic barrier development 
truncated the total number of WT and Krt14C373A available for direct 
comparison within each genotype and sex.  Additionally, postnatal pups were not 
anesthetized and TEWL readings were likely affected by heart rate and 
movement as TEWL measurements are not only dependent on the barrier status 
but also blood flow, as seen by laser doppler flowmetry (Endo et al., 2007).  
Furthermore, the TEWL assessment also has limitations and results 
should be conservatively interpreted. TEWL evaluates the epidermal barrier in a 
unidirectional fashion that is formally indicative of the inside to outside barrier 
function (Prokschet et al., 2008). However, this not always indicative of the 
reverse functionality and for determination of outside-inside function other 
alternative assays, e.g., dye penetration and retention into the skin, need to be 
performed. Dye penetration assays, assessing outside to inside barrier function, 
are challenging to perform and interpret.  It is likely there is a phenotype at earlier 
stages of barrier development and function however our methods may lack the 
sensitivity necessary for resolution under these conditions. 
In the setting of EBS and Krt14 null skin, mechanical stress results in a 
devastating blistering response that is manifested early after birth (Coulombe, 
2016). In the Krt14C373A mutant mice blistering does not occur in ear skin, tail, 
and paw tissues at any time, including early after birth. Instead, the Krt14C373A 
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mice exhibit a mild, subclinical skin phenotype under baseline conditions. Subtle 
changes in barrier homeostasis and physiologic response was revealed following 
investigation of TEWL at baseline and following provocation, with acetone. 
Significant alterations of SC morphology are recognized by altered CE morphology 
at baseline relative to WT. Collectively, these findings expand the notion that 
Krt14C373A as a contributor to terminal differentiation and barrier homeostasis in 
skin.  
Previous findings in our lab show that the perinuclear keratin network is 
altered by the elimination of K14-dependent disulfide bonding, resulting in altered 
nucleus shape and size. Our most recent findings show the ablation of a single 
cysteine from K14 impacts CE structure, lipid content, and SC physiology in vivo. 
However, the molecular mechanism whereby K14-dependent disulfide bonding 
and, in particular, residue C373 in K14, modulate skin barrier function has yet to 
be defined. 
 Recent work in the laboratory suggests that the Hippo signaling pathway 
may be the mechanistic link between Krt14C373A and K14 disulfide bonding. 
Protein levels of 14-3-3 and localization of YAP in tissue samples from Krt14C373A 
differ from WT (data not shown). Additionally, our mutant mouse exhibits a defect 
in differentiation which was revealed by altered localization of K14, K10, and 
filaggrin immunofluorescence staining.  One component of the Hippo pathway, 
YAP, has been shown inhibit terminal differentiation in mice and expand basal 
progenitor cells in the epidermis (Zhang, Pasolli & Fuchs, 2011).	 We believe we 
are seeing an expansion of basal progenitor cells in our mutant epidermis. 
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Additionally, the formation of the CE is a direct result of terminal differentiation 
processes; the irregular CE morphology in Krt14C373A stratum corneum may be 
due to underlying mechanics related to inhibited terminal differentiation. 
There may be therapeutic promise in understanding the signaling pathways 
that relate to disulfide bonded K14 and skin barrier response and environmental 
stressors since barrier abnormalities are directly proportional to disease severity 
and such anomalies may act as a driver of disease pathogenesis (Elias, 2014). 
For example, researchers attribute the inflammation seen in atopic dermatitis to 
defects in structural and enzymatic components of the SC, with an emphasis on 
extracellular organization and lipid compartments (Elias, 2014).  
Continued examination of the consequences of altered K14-dependent 
disulfide bonding in vivo is warranted as several common skin disorders, such as 
psoriasis and atopic dermatitis, involve diminished skin barrier function – yet the 
underlying mechanisms remain incompletely understood. Therefore, a 
comprehensive understanding of keratin network formation and assembly, which 
rely on disulfide bonded K14, in epidermal barrier function is imperative due to its 
potential impact on understanding a variety of common skin conditions 






Preparation of epidermal sheets by Ammonium-Thiocyanate  
Wera Roth October 2009 
Buffers: 1 M Na2HPO4   M=141.96 g/mol  200 ml = 
28.39 g 
  1 M NaH2PO4 x H2O M=137.99g/mol  200 ml = 27.60 g 
Preparation of 0.1 M Sodium Phosphate Buffer, pH 6.8 (see Maniatis, B.21): 
 
250 ml  11.575 ml  1 M Na2HPO4 
  13.425 ml 1 M NaH2PO4 ad 250 ml with H2O 
Preparation of 0.5 M Ammonium-Thiocyanate in 0.1 M Sodium Phosphate Buffer, 
pH 6.8: 
100 ml 3.81 g Ammonium-Thiocyanate   M=76.12 g/mol 
ad 100 ml with 0.1 M Sodium Phosphate Buffer, pH 6.8 (prepare fresh) 
1) Warm-up 0.5 M Ammonium-Thiocyanate in 0.1 M Sodium Phosphate 
Buffer, pH 6.8 to 37°C. 
2) Prepare full-thickness skin. 
3) Spread skins on plastic using forceps, epidermis up and dermis down. 
4) Float skins by adding 0.5 M Ammonium-Thiocyanate solution. 
5) Incubate 20-25 (max.) min at 37°C. 
6) Rinse in PBS. 
7) Take off epidermis. 




Preparation of Cornified Envelopes 
From: Magin Laboratory Protocol P59 by Wera Roth, 15.02.2010 (according to 
Hohl D. et al., 1991, J. Biol. Chem. 266: 6626-6636 and Jarnik M. et al., 1996, J. 
Cell Science 109: 1381-1391) 
1) Preparation of epidermal sheets using NH4-Thiocyanate solution (see 
P58). 
2) Alternatively, newborn total skin can be used. 
3) Cut tissue into pieces. 
4) Epidermal sheets / total skin are heated with stirring in CE-extraction 
buffer for 
5) 20-40 min at 95°C. Use 5 ml per epidermis and 10 ml per skin on a boiling 
6) water bath with vigorous stirring. 
a. Optional: Quick-freeze in LN2 and store at -80°C until further 
processing. 
7) CEs are collected by centrifugation at 5000 x g for 15 min at RT. 
8) CEs are washed twice at RT with CE-extraction buffer containing 0.2% 
SDS. 
9) CEs are collected by centrifugation at 5000 x g for 15 min. 
10) Suspend in 2% SDS solution. 
11) Adjust/determine CE concentration in a hemacytometer. 
12) Sonication (Branson 2210 cup sonicator) at 4°C, 20°C, 30°C, and 60°C. 
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13) At various time points, remove CE aliquots from the sonicator, count with 
the 
14) hemacytometer and photograph. 
a. Final CE preps can be stored at 4°C for up to several weeks. 
b. Optional: Drop CEs (50μl) on a glass slide and embed in Mowiol. 
15) CE-extraction buffer: 
a. M Tris/HCl, pH 8.5 
b. 2% SDS 
c. 20 mM DTT 
d. 5 mM EDTA 
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Toluidine Blue Barrier Function Assay  
 From DiTamasso et al., 2014 and Hardman et al., 1998 
Materials and Reagents 
1) E18.5 embryos from mice 
2) Chilled methanol in water (25%, 50%, 75% and 100% MetOH) 
3) 0.1% toluidine blue (in water) (Sigma-Aldrich) 
4) Chilled 1x PBS (pH 7.4) (Sigma-Aldrich, catalog number: P4417 ) 





1) Isolate uterus from pregnant females to obtain E18.5 embryos. 
2) Euthanize embryos by immersion in ice cold PBS for 30 min. 
3) At 18.5 days gestation, cull mother by cervical dislocation. Make a ventral 
incision and remove the uterine horn containing the embryos. To 
euthanize embryos, immerse entire uterus containing embryos in ice cold 
PBS for 30 min. Separate embryos and remove from uterus. Check that 
embryos have been successfully euthanized by pinching toe or tail with 
forceps. If embryo responds, place back into ice cold PBS and check 
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every 5 min. Once embryos are unresponsive/culled, proceed to the next 
step. 
4) Finger/toe clip individual embryos for identification. This is especially 
important when crossing heterozygous mice. The digits can be used for 
genotyping the embryos. 
5) Passage embryos through chilled methanol gradient, taking 2 min per 
step. It is crucial to have all solutions at 4 degrees centigrade. Keep 
solutions on ice throughout protocol. 
a. 25% methanol in water 
b. 50% methanol in water 
c. 75% methanol in water 
d. 100% methanol  
e. 75% methanol in water 
f. 50% methanol in water 
g. 25% methanol in water 
h. 100% water or PBS 
6) Immerse embryos in 0.1% toluidine blue solution in water for 1-2 min on 
ice. 
7) Destain embryos in PBS (pH 7.4) until a dye pattern emerges (in case of 
barrier defect) or until dye is washed away (in case of intact barrier) on 
ice. 
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8) Take pictures of individual embryos and if relevant genotype embryos. 
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and malignant melanoma, and atypical nevi. Responsibilities included: communicating 
pathology, recording patient histories on EMR, providing wound care, preparing 
examinations rooms for surgical procedures, biopsies and follow-up examinations. 
Interacted with patients, pharmacies, pharmaceutical companies/representatives, and 
insurance companies. Personally created and implemented surgical checklists at MSMS 
to ensure standardization of patient care. Provided patient care as a team member, 
established meaningful relationships with clients to ensure loyalty and promote positive 
& individualized patient care. I became CPR/AED Professional Rescuer/Health Provider 
certified. In addition, I was able to procure supplemental health benefits for over 500 
underinsured employees.   
 
Feldman E.N.T.  Medical Assistant 2011. Chevy Chase, MD 
 
Krystynne Aguirre Leacock 
DOB: 12/21/1988 
Location of Birth: Washington D.C. 
Current Address: 2313 Maryland Ave., Baltimore, MD 21218 
Current Phone: 304.237.1649 
E-mail Address: kleacoc1@jhu.edu 
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Worked as a medical assistant in a multi-facility otolaryngology practice to ensure 
optimal patient care during routine and emergency office visits, by performing 
administrative and clinical duties: patient histories and vitals on chart or electronic 
medical records. I prepared examination rooms and assisted during examinations and 
procedures. I ensured the sanitation and maintenance of exam rooms and equipment 
and handled specimens, confidential records, and time-sensitive materials. Scheduled 
appointments and responded to patient requests.   
 
Independent Student Research, Developmental Genetics, WVU 
Biology Department 2010-2011. Morgantown, WV 
 
Investigated the effect of CK2 on the structure and function of chromatin using 
D.melanogaster and a PEV reporter gene. Investigated the evolutionary conservation of 
CK2’s recognition sequence on potential targets across M.muluscus and H.sapiens. 
Worked independently to compile, analyze, and present results. Maintained and 
manipulated D.melanogaster stock, measured experimental variables, and analyzed 
consensus sequences using ClustalW. Routinely sterilized equipment and reagents 
according to established protocols. 
 
Capstone Research, WVU Biology Department 2010-2011. 
Morgantown, WV 
 
Investigated environmental effects of heavy metals and increased carbon dioxide on 
Chlorella pyreniodosa. Leader in project management while collaborating with a team of 
student researchers to generate and analyze data to present results. Duties included 
sterilization of equipment, reagent creation, microscopic observations, and routine 
measurement and care of algal growth. 
 
Research Assistant, Population Genetics, WVU Biology Department 
2008-2009. Morgantown, WV 
 
Investigated the effects of environmental influences on Populus trichocarpa using 
hydroponic solutions at the WVU Greenhouse and WVU Agronomy farm. Assisted in the 
harvest for the procurement of data to measure research variables using PCR, gel 
electrophoresis, DNA extraction and purification.  Worked with a research team in the 




Western Blot Analysis 
Genotyping 
Histologic Techniques  
Microscopy 
Investigation required western blot analysis, genotyping, tissue sectioning with OTC and 
paraffin embedding, Immuno-flourescence staining, confocal microscopy, protein 
extraction, acrylamide gel electrophoresis, dermal and epidermal extractions, trans-
epidermal water-loss measurements, and mouse colony management. 
 
